parkinson-s-disease

Documents about parkinson-s-disease

• Strategy Use Among People With Parkinson's Disease During the Weekly Calendar Planning Activity.#326880NCBI PubMed Central
• Diffusion-Informed Joint Segmentation Enhances Detection of Thalamic Atrophy in Parkinson's Disease.#334899NCBI PubMed Central
• Social cognition in Parkinson's disease: a comprehensive systematic review and integrative conceptual framework.#367958NCBI PubMed Central
• SPARROW: subtyping Parkinson's disease with agentic reasoning and robust omics workflow.#368056NCBI PubMed Central
• Cognitive structure and progression in Parkinson's disease: insights from a tablet-based assessment.#375174NCBI PubMed Central
• Neural network plasticity in Parkinson's disease: the impact of exercise-driven modulation.#402736NCBI PubMed Central
• Short term heart rate variability is preserved in Parkinson’s disease under atomoxetine#424635Europe PMC
• Digital profiling of dysarthria in late- and early-onset Parkinson's disease.#437236NCBI PubMed Central
• Comparing different neuroimaging modalities for quantification of the cholinergic system in Parkinson's disease#456610bioRxiv / medRxiv
• Volitional deep brain stimulation following brain-computer interface training for Parkinson’s disease#478522Europe PMC
• Polygenic scores contribution to Parkinson's disease comorbidities#654633Repositorio Universidad del Desarrollo
• Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation#803610ClinicalTrials.gov
• A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin#832704ClinicalTrials.gov
• Perceptual Decision Making Under Conditions of Visual Uncertainty#848386ClinicalTrials.gov
• A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects#867158ClinicalTrials.gov
• An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications#831294ClinicalTrials.gov
• Use of machine learning and voice for multiclass classification of Parkinson's disease, chronic obstructive pulmonary disease, and healthy controls.#213975NCBI PubMed Central
• Clinical characteristics and predictors of disease progression in parkinson's disease in a cohort of patients in the ashanti region, Ghana.#267001NCBI PubMed Central
• The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.#366530ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients#424239ClinicalTrials.gov
• Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067#834047ClinicalTrials.gov
• Effects of physical exercise on cognitive impairment in patients with Alzheimer's disease, Parkinson's disease or mild cognitive impairment: a systematic review and meta-analysis.#288888NCBI PubMed Central
• Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy#803648ClinicalTrials.gov
• Parkinson's disease dementia and hearing impairment, are they related? A UK biobank pilot analysis.#616NCBI PubMed Central
• Augmented reality rehabilitation at home for adults with Parkinson's disease: a feasibility study#4880Europe PMC
• Author Correction: TMEM175, SCARB2 and CTSB associations with Parkinson's disease risk across populations#120136Europe PMC
• Risk of Parkinson’s disease in patients with schizophrenia: Impact of antipsychotic medication use.#154609NCBI PubMed Central
• Parkinson's disease-linked D620N mutation selectively alters the brain-specific protein interactome of VPS35#176508bioRxiv / medRxiv
• Modeling cis-regulatory variation in human brain enhancers across a large Parkinson's Disease cohort#189364bioRxiv / medRxiv
• Machine Learning Approaches to Early Detection of Parkinson's Disease Using Speech Analysis Technique.#232287NCBI PubMed Central
• Automatic and explainable assessment for Parkinson's disease by video-based human motion understanding.#236286NCBI PubMed Central
• Reflexive eye movement alterations are related to subclinical impulsive-compulsive behaviors in Parkinson's disease.#298717NCBI PubMed Central
• DBSsync: combining intracranial and multimodal data to investigate new biomarkers in Parkinson's disease#311545Europe PMC
• Data-Driven Robust Machine Learning Models to Differentiate Parkinson's Disease Patients Using Heterogeneous Risk Factors#341974bioRxiv / medRxiv
• Cospeech gestures are a window into the effects of Parkinson's disease on action representations#347529Goldsmiths Research Online
• Knowledge and Misconceptions About Parkinson's Disease in Lebanon: A Cross-Sectional Survey.#354930NCBI PubMed Central
• Generalization over accuracy: A cross-dataset, explainable, and federated learning framework for Parkinson's disease detection.#358324NCBI PubMed Central
• Care partner needs in Parkinson's disease: A systematic review of qualitative and quantitative data.#360828NCBI PubMed Central
• Sphingolipid-Neuroinflammation Axis in Parkinson's Disease: Focus on S1P/SPHK1-NF‑κB Signaling.#368085NCBI PubMed Central
• Gait characteristics align with a clinically defined biological staging system in Parkinson’s disease#374177Europe PMC
• Psychosocial interventions affecting global perceptions of control in people with Parkinson's disease : a scoping review#374977Lancaster EPrints
• Stratified cohorts for biomarker assessment and trial readiness: TMEM175, SCARB2 and CTSB in Parkinson's disease#398157bioRxiv / medRxiv
• MRI-Based Texture Analysis of the Extraocular Optic Nerve in Idiopathic Parkinson's Disease.#409481NCBI PubMed Central
• Blood transcriptomics reveals a Parkinson's disease signature and heterogeneous prodromal molecular profiles in isolated RBD#417377bioRxiv / medRxiv
• Accelerometry-Derived REM Sleep Behavior Disorder Predicts Future Parkinson's Disease in the UK Biobank#424124bioRxiv / medRxiv
• Environmental determinants of Parkinson’s disease and attributable burden in Latin America#427118Europe PMC
• Basal ganglia neurophysiological markers of non-motor symptoms in Parkinson's disease: A systematic review.#430926NCBI PubMed Central
• Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson’s disease#446892ResearchOnline@ND
• Fully-automated sleep staging for Parkinson's disease and isolated REM sleep behavior disorder.#458634NCBI PubMed Central
• Smartwatch-Based Screening to Identify Candidates for Deep Brain Stimulation in Parkinson's Disease.#469096NCBI PubMed Central